Evaluation of PD-L1 expression on tumor cells using flow cytometry confirmed higher PD-L1 expression on IFN-γ treated tumors compared to PBS treated tumors, although PD-L1 expression levels were low (Figure 5E). The gene discussed is IFNG; the disease is neoplasm.